FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Is Mom late on bills? Could be sign of dementia, report finds
By
Kristen Fischer
Jun 05, 2024
Older adults who fall behind on paying their bills may have early signs of dementia and be susceptible to further financial risks, according to a recent report.
Study spots brain clusters linked to subjective memory complaints
By
Kristen Fischer
May 23, 2024
People with subjective memory complaints include two subgroups, and being in the lower performance cluster increased the risk for cognitive impairment, according to a study published Thursday in Alzheimer’s...
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.